Source: Annual Congress 2008 - Structural remodelling in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. A. Martinez Cortizas, M. P. Pereiro, C. N. Artana, N. Pistillo, J. J. Scarimbolo, J. M. Figueroa (Avellaneda/Buenos Aires, Caba, Argentina). CRP and LTE4 in COPD. Eur Respir J 2008; 32: Suppl. 52, 708

Member's Comments

No comment yet.

Related content which might interest you: Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016 Neutrophil elastase and IL-8 assessment in patients with COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Urinary cysteinyl leukotriene levels in acute asthma Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Mepolizumab decreases urinary excretion of LTE4 in severe asthma Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 The study of bronchospastic eicosanoids levels in asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003 COPD, asthma and C-reactive protein Source: Eur Respir J 2006; 27: 874-876 Year: 2006 Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 Corticosteroid reversibility testing and exhaled leukotriene B4 in patients with stable, severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Plasma leukotriene level in atopic and non-atopic asthmatic children and its correlation to severity of the disease Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003 PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021 Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Increased exhaled 8-isoprostane in aspirin-sensitive asthma Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Leukotriene B4 in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008